Lataa...
Sunitinib: the antiangiogenic effects and beyond
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma. Mechanistically, sunitinib inhibits multiple receptor tyrosine kinases, especially those involved in angiogen...
Tallennettuna:
| Julkaisussa: | Onco Targets Ther |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5021055/ https://ncbi.nlm.nih.gov/pubmed/27660467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S112242 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|